Drug Type Autologous CAR-T |
Synonyms |
Target |
Mechanism L1CAM antagonists(L1 cell adhesion molecule antagonists), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | KR | 04 Apr 2023 | |
Ovarian Cancer | Preclinical | KR | 04 Apr 2023 | |
Stomach Cancer | Preclinical | KR | 04 Apr 2023 | |
Stomach Cancer | Preclinical | KR | 04 Apr 2023 | |
Lung Cancer | Preclinical | KR | - | |
Neuroblastoma | Preclinical | KR | - |